Eupraxia Pharmaceuticals Quote - EPRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

4.40

Bid

4.40

Offer

4.49

Volume

10,326

4.40 Day's Range 4.49

3.07 52 Week Range 7.64

Market Cap

120.041M

Previous Close

4.49

Open

4.41

Last Trade

100

4.4

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

31,653

Shares Outstanding

27,282,000

Dividend Yield

PE Ratio

-4.27

Earnings Per Share (EPS)

-1.03

Revenue

Net Profit

-28.22M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eupraxiapharma.com

Headquarters

Victoria, British Columbia, Can

Founded

Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $4.49. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3.07 to $ 7.64.

Eupraxia Pharmaceuticals currently has 27,282,000 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is $122.50 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.27.

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months Canada NewsWire VICTORIA, BC, Nov. 20, 2024...

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting Canada NewsWire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /CNW/ - Eupraxia...

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.227790432802	4.39	4.49	4.35	3667	4.42863636	CS
4	-0.49	-10.0204498978	4.89	4.95	4.13	11066	4.57587443	CS
12	1.08	32.5301204819	3.32	5.45	3.07	31653	4.22095484	CS
26	0.9	25.7142857143	3.5	5.45	3.07	23223	3.97576819	CS
52	-1.1	-20	5.5	7.64	3.07	33037	4.30395004	CS
156	2.09	90.4761904762	2.31	9.1	0.8	27395	4.29931377	CS
260	-3.35	-43.2258064516	7.75	9.1	0.8	25005	4.23742706	CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?

The current share price of Eupraxia Pharmaceuticals is $ 4.40

How many Eupraxia Pharmaceuticals shares are in issue?

Eupraxia Pharmaceuticals has 27,282,000 shares in issue

What is the market cap of Eupraxia Pharmaceuticals?

The market capitalisation of Eupraxia Pharmaceuticals is CAD 122.5M

What is the 1 year trading range for Eupraxia Pharmaceuticals share price?

Eupraxia Pharmaceuticals has traded in the range of $ 3.07 to $ 7.64 during the past year

What is the PE ratio of Eupraxia Pharmaceuticals?

The price to earnings ratio of Eupraxia Pharmaceuticals is -4.27

What is the reporting currency for Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals reports financial results in USD

What is the latest annual profit for Eupraxia Pharmaceuticals?

The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M

What is the registered address of Eupraxia Pharmaceuticals?

The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.

What is the Eupraxia Pharmaceuticals website address?

The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com

Which industry sector does Eupraxia Pharmaceuticals operate in?

Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BSXBelo Sun Mining Corp	$ 0.075 (66.67%)	2.95M
GCUGunnison Copper Corp	$ 0.20 (17.65%)	217.52k
KLSKelso Technologies Inc	$ 0.14 (16.67%)	10.5k
COPRCoppernico Metals Inc	$ 0.255 (13.33%)	60.77k
PPRPrairie Provident Resources Inc	$ 0.045 (12.50%)	979.01k
BABYElse Nutrition Holdings Inc	$ 0.015 (-25.00%)	1.26M
RTGRTG Mining Inc	$ 0.03 (-25.00%)	39.42k
GMTNGold Mountain Mining Corp	$ 0.025 (-16.67%)	391.1k
DBOD Box Technologies Inc	$ 0.135 (-15.63%)	2.34M
LSPKLifeSpeak Inc	$ 0.34 (-15.00%)	3k
CMCanadian Imperial Bank of Commerce	$ 91.07 (0.46%)	8M
TRPTC Energy Corporation	$ 67.04 (0.45%)	7.74M
TTelus Corp	$ 19.30 (-0.82%)	6.27M
ENBEnbridge Inc	$ 60.49 (0.32%)	6.07M
MFCManulife Financial Corporation	$ 44.00 (-0.65%)	5.04M